151 related articles for article (PubMed ID: 33230783)
1. SUCLG1 mutations and mitochondrial encephalomyopathy: a case study and review of the literature.
Molaei Ramsheh S; Erfanian Omidvar M; Tabasinezhad M; Alipoor B; Salmani TA; Ghaedi H
Mol Biol Rep; 2020 Dec; 47(12):9699-9714. PubMed ID: 33230783
[TBL] [Abstract][Full Text] [Related]
2. Clinical, Molecular, and Computational Analysis in two cases with mitochondrial encephalomyopathy associated with SUCLG1 mutation in a consanguineous family.
Maalej M; Tej A; Bouguila J; Tilouche S; Majdoub S; Khabou B; Tabbebi M; Felhi R; Ammar M; Mkaouar-Rebai E; Keskes L; Boughamoura L; Fakhfakh F
Biochem Biophys Res Commun; 2018 Jan; 495(2):1730-1737. PubMed ID: 29217198
[TBL] [Abstract][Full Text] [Related]
3. Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.
Carrozzo R; Verrigni D; Rasmussen M; de Coo R; Amartino H; Bianchi M; Buhas D; Mesli S; Naess K; Born AP; Woldseth B; Prontera P; Batbayli M; Ravn K; Joensen F; Cordelli DM; Santorelli FM; Tulinius M; Darin N; Duno M; Jouvencel P; Burlina A; Stangoni G; Bertini E; Redonnet-Vernhet I; Wibrand F; Dionisi-Vici C; Uusimaa J; Vieira P; Osorio AN; McFarland R; Taylor RW; Holme E; Ostergaard E
J Inherit Metab Dis; 2016 Mar; 39(2):243-52. PubMed ID: 26475597
[TBL] [Abstract][Full Text] [Related]
4. The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein.
Rouzier C; Le Guédard-Méreuze S; Fragaki K; Serre V; Miro J; Tuffery-Giraud S; Chaussenot A; Bannwarth S; Caruba C; Ostergaard E; Pellissier JF; Richelme C; Espil C; Chabrol B; Paquis-Flucklinger V
J Med Genet; 2010 Oct; 47(10):670-6. PubMed ID: 20693550
[TBL] [Abstract][Full Text] [Related]
5. A novel homozygous mutation in SUCLA2 gene identified by exome sequencing.
Lamperti C; Fang M; Invernizzi F; Liu X; Wang H; Zhang Q; Carrara F; Moroni I; Zeviani M; Zhang J; Ghezzi D
Mol Genet Metab; 2012 Nov; 107(3):403-8. PubMed ID: 23010432
[TBL] [Abstract][Full Text] [Related]
6. A novel missense mutation in SUCLG1 associated with mitochondrial DNA depletion, encephalomyopathic form, with methylmalonic aciduria.
Ostergaard E; Schwartz M; Batbayli M; Christensen E; Hjalmarson O; Kollberg G; Holme E
Eur J Pediatr; 2010 Feb; 169(2):201-5. PubMed ID: 19526370
[TBL] [Abstract][Full Text] [Related]
7. Expanding the phenotypic spectrum of Succinyl-CoA ligase deficiency through functional validation of a new SUCLG1 variant.
Donti TR; Masand R; Scott DA; Craigen WJ; Graham BH
Mol Genet Metab; 2016 Sep; 119(1-2):68-74. PubMed ID: 27484306
[TBL] [Abstract][Full Text] [Related]
8. [SUCLA2-related encephalomyopathic mitochondrial DNA depletion syndrome: a case report and review of literature].
Liu Z; Fang F; Ding C; Wu H; Lyu J; Wu Y
Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):817-21. PubMed ID: 25582465
[TBL] [Abstract][Full Text] [Related]
9. Novel mutation in SUCLA2 identified on sequencing analysis.
Güngör O; Özkaya AK; Güngör G; Karaer K; Dilber C; Aydin K
Pediatr Int; 2016 Jul; 58(7):659-61. PubMed ID: 26952923
[TBL] [Abstract][Full Text] [Related]
10. Mutated SUCLG1 causes mislocalization of SUCLG2 protein, morphological alterations of mitochondria and an early-onset severe neurometabolic disorder.
Chinopoulos C; Batzios S; van den Heuvel LP; Rodenburg R; Smeets R; Waterham HR; Turkenburg M; Ruiter JP; Wanders RJA; Doczi J; Horvath G; Dobolyi A; Vargiami E; Wevers RA; Zafeiriou D
Mol Genet Metab; 2019 Jan; 126(1):43-52. PubMed ID: 30470562
[TBL] [Abstract][Full Text] [Related]
11. Novel compound heterozygous SUCLG1 variants may contribute to mitochondria DNA depletion syndrome-9.
Chen YM; Chen W; Xu Y; Lu CS; Zhu MM; Sun RY; Wang Y; Chen Y; Shi J; Wang D
Mol Genet Genomic Med; 2022 Sep; 10(9):e2010. PubMed ID: 35762302
[TBL] [Abstract][Full Text] [Related]
12. Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder.
Randolph LM; Jackson HA; Wang J; Shimada H; Sanchez-Lara PA; Wong DA; Wong LJ; Boles RG
Mol Genet Metab; 2011 Feb; 102(2):149-52. PubMed ID: 21093335
[TBL] [Abstract][Full Text] [Related]
13. Five novel SUCLG1 mutations in three Chinese patients with succinate-CoA ligase deficiency noticed by mild methylmalonic aciduria.
Liu Y; Li X; Wang Q; Ding Y; Song J; Yang Y
Brain Dev; 2016 Jan; 38(1):61-7. PubMed ID: 26028457
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion.
Matilainen S; Isohanni P; Euro L; Lönnqvist T; Pihko H; Kivelä T; Knuutila S; Suomalainen A
Eur J Hum Genet; 2015 Mar; 23(3):325-30. PubMed ID: 24986829
[TBL] [Abstract][Full Text] [Related]
15. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
Carrozzo R; Dionisi-Vici C; Steuerwald U; Lucioli S; Deodato F; Di Giandomenico S; Bertini E; Franke B; Kluijtmans LA; Meschini MC; Rizzo C; Piemonte F; Rodenburg R; Santer R; Santorelli FM; van Rooij A; Vermunt-de Koning D; Morava E; Wevers RA
Brain; 2007 Mar; 130(Pt 3):862-74. PubMed ID: 17301081
[TBL] [Abstract][Full Text] [Related]
16. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion.
Elpeleg O; Miller C; Hershkovitz E; Bitner-Glindzicz M; Bondi-Rubinstein G; Rahman S; Pagnamenta A; Eshhar S; Saada A
Am J Hum Genet; 2005 Jun; 76(6):1081-6. PubMed ID: 15877282
[TBL] [Abstract][Full Text] [Related]
17. A
Landsverk ML; Zhang VW; Wong LC; Andersson HC
Mol Genet Metab Rep; 2014; 1():451-454. PubMed ID: 27896121
[TBL] [Abstract][Full Text] [Related]
18. SUCLG1 restricts POLRMT succinylation to enhance mitochondrial biogenesis and leukemia progression.
Yan W; Xie C; Sun S; Zheng Q; Wang J; Wang Z; Man CH; Wang H; Yang Y; Wang T; Shi L; Zhang S; Huang C; Xu S; Wang YP
EMBO J; 2024 Jun; 43(12):2337-2367. PubMed ID: 38649537
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations.
Ostergaard E; Hansen FJ; Sorensen N; Duno M; Vissing J; Larsen PL; Faeroe O; Thorgrimsson S; Wibrand F; Christensen E; Schwartz M
Brain; 2007 Mar; 130(Pt 3):853-61. PubMed ID: 17287286
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients.
Navarro-Sastre A; Tort F; Garcia-Villoria J; Pons MR; Nascimento A; Colomer J; Campistol J; Yoldi ME; López-Gallardo E; Montoya J; Unceta M; Martinez MJ; Briones P; Ribes A
Mol Genet Metab; 2012 Nov; 107(3):409-15. PubMed ID: 22980518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
